Providing digital solutions to educational/clinical fields. Announcing the release of the Digital Sight 1000 microscope camera

June 29, 2020 Nikon Corporation (Nikon) is pleased to announce the release of the Digital Sight 1000 microscope camera, providing digital solutions to educational/clinical fields. Product Information The microscope camera can obtain images during observation on the display in combination with a microscope. Digital solutions are currently in demand in many fields, with digital images... Read more

FDA approves Roche’s Phesgo (fixed-dose combination of Perjeta and Herceptin for subcutaneous injection) for HER2-positive breast cancer

             Basel, 29 June 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has approved Phesgo™, a fixed-dose combination of Perjeta® (pertuzumab) and Herceptin® (trastuzumab) with hyaluronidase, administered by subcutaneous (SC; under the skin) injection in combination with intravenous (IV) chemotherapy, for the treatment of early and... Read more

Roche announces new data at the ISTH 2020 Congress, demonstrating ongoing commitment to advancing care for people with haemophilia A

Spark Therapeutics will present data from the initial dose cohorts of its phase I/II SPK-8011 gene therapy study, showing stable and durable factor VIII expression, substantial improvement in annualised bleed rate for more than two years, and an acceptable safety profile after more than two years of follow-up1 Roche will present second interim analysis results... Read more

Xylem Closes $1 Billion Inaugural Green Bond

Proceeds will fund eligible projects under Green Finance Framework Further enhances strong liquidity position, adds flexibility at attractive rates Builds on sustainability track record and recognized sustainability leadership in sector RYE BROOK, N.Y.–(BUSINESS WIRE)–Jun. 29, 2020– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues,... Read more

Roche’s ENSPRYNG®️ (satralizumab) approved in Japan for adults and children with neuromyelitis optica spectrum disorder

ENSPRYNG is Japan’s first and only approved therapy for both adults and children with neuromyelitis optica spectrum disorder (NMOSD) ENSPRYNG is the first and only approved therapy targeting the interleukin-6 (IL-6) receptor given subcutaneously every four weeks Approval is supported by data demonstrating ENSPRYNG’s robust efficacy, which was well-tolerated with a consistent safety profile, in... Read more

Roche improves speed and accuracy of non-small cell lung cancer diagnosis with launch of automated digital pathology algorithm

uPath PD-L1 (SP263) image analysis uses automated pre-computing and one-click scoring to enable quicker and accurate detection and measurement of tumour cell staining positivity Roche advances personalised healthcare with development of image analysis algorithms using artificial intelligence Faster, more accurate diagnoses are critical with non-small cell lung cancer, which accounts for about 85 percent of... Read more

BURLINGAME, CA – June 25, 2020 – Halo Labs, a life science instrumentation company developing tools for biologics researchers, today announced it has launched its latest aggregate and particle identification system, called Aura™. Aura is the next generation of the Horizon®, Halo Labs’ popular Backgrounded Membrane Imaging (BMI) platform. With as little as 5 µL and a linear range... Read more

13C–13C spin-coupling constants in crystalline 13C-labeled saccharides: conformational effects interrogated by solid-state 13C NMR spectroscopy

   From the journal: Physical Chemistry Chemical Physics   Abstract Solid-state 13C NMR spectroscopy has been used in conjunction with selectively 13C-labeled mono- and disaccharides to measure 13C–13C spin-couplings (JCC) in crystalline samples. This experimental approach allows direct correlation of JCC values with specific molecular conformations since, in crystalline samples, molecular conformation is essentially static and can be determined by... Read more

Waters Extends the Capability and Power of its High-Resolution Mass Spectrometers

Enhancements for the Waters Xevo G2-XS QTof, SYNAPT XS and SELECT SERIES Cyclic IMS Instruments Accelerate Biomedical and Pharmaceutical Research Milford, Mass. – June 23, 2020 – Waters Corporation (NYSE:WAT) announced today a new fragmentation technique and an imaging option for its high-resolution mass spectrometers giving research scientists working across a broad range of end markets... Read more

Waters Introduces the New Arc High-Performance Liquid Chromatograph to Help Laboratories Meet Quality and Production Targets

Modern LC System Replicates Established Test Methods, Delivers Improved Performance; Updates to Lab Business Continuity Solution Also Announced Milford, Mass. – June 23, 2020 – Waters Corporation (NYSE:WAT) today introduced the Waters™ Arc™ HPLC System, a new high-performanceliquid chromatograph (HPLC) for routine testing in the pharmaceutical, food, academic and materials markets. A key target application is... Read more